David Lebowitz Score: 38
Analyst at
BMO Capital
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+23.7%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
58%
11 W / 8 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
69%
9 W / 4 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
15%
2 W / 11 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
8%
1 W / 12 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
62%
8 W / 5 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
61%
11 W / 7 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$290.00
Est. +67%
|
$174.00 | $180.61 |
Pending
|
$161.08
-7.4%
|
| Oct 30, 2026 |
Exelixis Inc
EXEL
|
SELL |
$60.00
Est. +9%
|
$66.20 | $67.23 (Low) |
Pending
|
$72.75
-9.9%
|
| Oct 21, 2026 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$66.00
Est. +49%
|
$44.27 | $45.84 |
Pending
|
$40.15
-9.3%
|
| Sep 04, 2026 |
Ionis Pharmaceuticals Inc
IONS
|
BUY |
$61.00
Est. +5%
|
$58.13 | $58.96 |
Pending
|
$40.15
-30.9%
|
| Aug 18, 2026 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$98.00
Est. +46%
|
$66.99 | $68.29 |
Pending
|
$57.11
-14.7%
|
| Aug 18, 2026 |
Akoustis Technologies Inc
AKTS
|
BUY |
$37.00
Est. +48%
|
$25.00 | $27.66 |
Pending
|
$15.20
-39.2%
|
Alnylam Pharmaceuticals Inc
ALNY
Oct 30, 2026
Signal & Target
BUY
$290.00
Start Price
$174.00
Best Price (1Y)
$180.61
Current Price
$161.08
Return
-7.4%
Exelixis Inc
EXEL
Oct 30, 2026
Signal & Target
SELL
$60.00
Start Price
$66.20
Best Price (1Y)
$67.23
Current Price
$72.75
Return
-9.9%
Ionis Pharmaceuticals Inc
IONS
Oct 21, 2026
Signal & Target
BUY
$66.00
Start Price
$44.27
Best Price (1Y)
$45.84
Current Price
$40.15
Return
-9.3%
Ionis Pharmaceuticals Inc
IONS
Sep 04, 2026
Signal & Target
BUY
$61.00
Start Price
$58.13
Best Price (1Y)
$58.96
Current Price
$40.15
Return
-30.9%
Signal & Target
BUY
$98.00
Start Price
$66.99
Best Price (1Y)
$68.29
Current Price
$57.11
Return
-14.7%
Akoustis Technologies Inc
AKTS
Aug 18, 2026
Signal & Target
BUY
$37.00
Start Price
$25.00
Best Price (1Y)
$27.66
Current Price
$15.20
Return
-39.2%